EDGAR Filing Documents for 0001047469-15-002607

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001047469-15-002607

Filing Date

2015-03-23

Accepted

2015-03-23 16:33:42

Documents

Period of Report

2014-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	a2223278z10-k.htm	10-K	798428
2	EX-14.1	a2223278zex-14_1.htm	EX-14.1	16919
3	EX-21.1	a2223278zex-21_1.htm	EX-21.1	1485
4	EX-23.1	a2223278zex-23_1.htm	EX-23.1	2208
5	EX-31.1	a2223278zex-31_1.htm	EX-31.1	8328
6	EX-31.2	a2223278zex-31_2.htm	EX-31.2	8390
7	EX-32.1	a2223278zex-32_1.htm	EX-32.1	4728
8	EX-32.2	a2223278zex-32_2.htm	EX-32.2	4784
15	G27097.JPG	g27097.jpg	GRAPHIC	72362
16	G694822.JPG	g694822.jpg	GRAPHIC	65493
17	G477529.JPG	g477529.jpg	GRAPHIC	42319
18	G869949.JPG	g869949.jpg	GRAPHIC	41714
	Complete submission text file	0001047469-15-002607.txt		4529853

Data Files

Seq	Description	Document	Type	Size
9	EX-101.INS	dprx-20141231.xml	EX-101.INS	454317
10	EX-101.SCH	dprx-20141231.xsd	EX-101.SCH	36758
11	EX-101.CAL	dprx-20141231_cal.xml	EX-101.CAL	24812
12	EX-101.DEF	dprx-20141231_def.xml	EX-101.DEF	113179
13	EX-101.LAB	dprx-20141231_lab.xml	EX-101.LAB	327463
14	EX-101.PRE	dprx-20141231_pre.xml	EX-101.PRE	226076

Mailing Address 61 BROADWAY SUITE 1905 NEW YORK NY 10006

Business Address 61 BROADWAY SUITE 1905 NEW YORK NY 10006 212-269-2834

Dipexium Pharmaceuticals, Inc. (Filer) CIK: 0001497504 (see all company filings)